Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation on the Clinical Efficacy of Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

NCT07034326 is registered in ClinicalTrials.gov with Kong Fanming as lead sponsor.

NCT NCT07034326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation on the Clinical Efficacy of Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
Lead sponsor
Kong Fanming
Phase
Phase 2/3
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2028
Enrollment
405 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

electroacupuncture, immune checkpoint inhibitors, non-small cell lung cancer